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tory of casual contact between its cit-
izens and the travelers and nonciti-
zens who reside there. 
Hospitals have functioned as junc-
tions for varied communities in
spreading the SARS virus further.
Because of SARS’likely place of ori-
gin, the initial “community” included
Chinese persons who then kindled the
chain of transmission to other com-
munities throughout the world. Daily,
close contact between SARS patients
and hospital personnel led to an
unusually large number of infections
among medical staff members.
Effective prevention measures such as
vaccines are not available and may be
a factor in the spread of the infection. 
Even in the era of globalization
and mass air transit, most persons live
inside a relatively small circle of com-
munity, made up of others of similar
ethnicity, religious beliefs, education-
al level, and social class who live in
the same vicinity; this sort of small
circle has been described as “mutual
coexistence” by anthropologist Kinji
Imanishi (1). Basically, the SARS-
associated coronavirus began circulat-
ing among members of such a com-
munity. This theory does not suggest
that certain ethnic groups are predis-
posed to be susceptible to SARS. 
Why have few cases of SARS
occurred in children? All age groups
are susceptible to the SARS virus,
which is new to humans. However,
adults have more chance to become
infected through contacts in their
daily lives, whereas children do not.
Rapid isolation of the adult patients
contributed to reduced frequency of
exposure for children in that house-
hold, which is in contrast to the usual
infectious diseases of childhood
(since children do not have immunity
against many age-old microbes).
Some contradictions exist for our
interpretation of the SARS transmis-
sion pattern. Investigations have
shown that in Canada, Hong Kong
and elsewhere, some casual brief con-
tact caused the infection or that the
link between the source and the case
was not at all clear. We may have
missed other important routes of
transmission, or a totally unknown
element may be involved. Without an
answer for this discrepancy, we note
that the clinical virology for SARS,
such as pattern of virus shedding and
host immune response, is still devel-
oping (2). For example, a total of 19
cases in China were identified as
SARS by coronavirus isolation, poly-
merase chain reaction, or serologic
tests. For two case-patients, the
results of three tests were positive; 10
case-patients had negative test results;
and in 14 case-patients, the virus was
not isolated. Interpreting these results
is difficult. In the United States, 97%
of the probable cases were attributed
to a recent history of international
travel to SARS-affected areas.
Antibodies to SARS-associated coro-
navirus were demonstrated for 8 of 41
probable case-patients in convales-
cent-phase serum, bringing the pro-
portion of laboratory-confirmed cases
to 20%, even in the probable cases,
and 0% among the suspected cases in
the United States so far (3). These
results are the best available by labo-
ratories with the current limited tech-
nical knowledge. We are not persuad-
ed that casual contact with SARS
patients in unfamiliar settings results
in contracting the disease.
The winter of 2003 will be critical
for observing how the virus behaves,
whether the winter climate accelerates
the transmission, and how we handle
that acceleration. Despite current
global efforts, thin lines of transmis-
sions may remain in China; the virus
may flare up again. Officials in China
and sites of the outbreak must inter-
rupt as many chains of transmission
as possible before October.
Surveillance should also be intensi-
fied. Ongoing study to improve labo-
ratory diagnosis and clinical virology
is key, so that effective isolation can
be practiced; at present, these meas-
ures are the only ones known to inter-
rupt the transmission of SARS. The
group on which to focus should be the
community in close contact with pre-
vious outbreak areas. 
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Home-prepared
Hamburger and
Sporadic Hemolytic
Uremic Syndrome,
Argentina
To the Editor: Argentina has the
highest incidence of hemolytic uremic
syndrome (HUS) in the world, and
10.4 cases per 100,000 children <5
years of age were reported in 2001.
HUS is the leading cause of acute
renal failure in children (1); in 20% to
35% chronic renal failure develops,
ranging from mild to serious, and
HUS is the second leading cause of
chronic renal failure (2,3) in
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Shiga toxin–producing Escherichia
coli (STEC) infection was found in
59% of Argentine HUS cases;
O157:H7 was the predominant
serotype isolated (4). Although out-
breaks of E. coli O157:H7 have been
linked to eating contaminated ground
beef (5), the organism is rarely isolat-
ed from the implicated meat, and the
sources of infection for sporadic cases
have rarely been identified. We report
a sporadic HUS case linked to the
consumption of home-prepared ham-
burger contaminated with E. coli
O157.
A 2-year-old girl was brought to
the emergency room of the Hospital
Nacional de Pediatría “Prof. Dr. Juan
Garrahan” in Buenos Aires on April
26, 2002, with a 1-day history of
bloody diarrhea. Results of a physical
examination were normal, and a stool
culture was requested. The patient
was sent home with dietary and gener-
al instructions. As watery diarrhea
persisted with vomiting and fever, the
girl was brought in again 3 days later.
At that time, she exhibited moderate
dehydration, pallor, drowsiness, and a
generalized seizure of 10 to 15 min
duration, tachycardia, tender and
tense abdominal wall, and a history of
oligoanuria for the last 48 h. Blood
pressure was 128/67 mm Hg. The
child was hospitalized with a pre-
sumptive diagnosis of HUS and
anuric renal failure.
Initial laboratory findings included
the following: hematocrit, 26%;
hemoglobin level, 8.8 g/dL; leukocyte
count, 34,800/mm3; segmented neu-
trophil count, 29,928/mm3; platelet
count, 91,000/mm3; serum glucose,
160 mg/dL; blood urea nitrogen
(BUN), 268 mg/dL; serum creatinine,
6.3 mg/dL; albumin, 1.7 g/dL; uric
acid,  14.8 mg/dL; calcium, 6.9
mg/dL; phosphorus, 6.7 mg/dL; mag-
nesium, 2.0 mg/dL; sodium, 113
mEq/L; potassium, 7.6 mEq/L; pH
7.28; bicarbonate, 10 mmol/L; base
excess, –14.9 mmol/L. Chest x-ray
findings were normal with a cardio-
thoracic index of 0.5; results of an
abdominal sonogram were normal. A
sonogram of the renal system also
showed that the kidneys were of nor-
mal shape and size and had increased
echogenicity. Results of a brain scan
showed nonspecific brain atrophy. 
The clinical findings and the labo-
ratory features of microangiopathic
hemolytic anemia, thrombocytopenia,
and acute renal failure were consistent
with the diagnosis of HUS. The
patient remained anuric for 17 days,
required 17 peritoneal dialysis proce-
dures, and six infusions of packed red
blood cells. One month after the acute
period, she had elevated BUN and
serum creatinine levels and massive
proteinuria. 
The rectal swab sample collected
on April 26 was routinely cultured for
E. coli,  Salmonella,  Shigella,
Yersinia,  Aeromonas,  Plesiomonas,
Vibrio, and  Campylobacter  species.
Sorbitol nonfermenting colonies were
recovered on sorbitol-MacConkey
(SMAC) agar (Difco Laboratories,
Detroit, MI) and SMAC supplement-
ed with cefixime (50 ng/mL) and
potassium tellurite (25 mg/mL) (CT-
SMAC). The bacterial confluent
growth zones of both SMAC and CT-
SMAC were positive for stx2 and
rfbO157 genes by multiplex poly-
merase chain reaction (PCR) using
the primers described by Pollard et al.
(6) and Paton et al. (7), respectively.
The E. coli O157 isolates were identi-
fied by standard biochemical methods
and serologic tests by using specific
O157 antiserum (INPB-ANLIS “Dr.
Carlos G. Malbrán”) and sent to the
Servicio Fisiopatogenia as National
Reference Laboratory (NRL) for fur-
ther characterization. 
As part of the case-control study
conducted in the pediatric hospital to
identify the risk factors associated
with the STEC infection, parents of
the 2-year-old girl were interviewed
with a standardized questionnaire 8
days after onset of symptoms.
Information was collected about her
clinical illness, potential exposures in
the 7 days before the onset of diar-
rhea, and demographic issues. Her
parents reported that on April 25 the
girl had eaten a home-prepared ham-
burger, made from ground beef pur-
chased from a local market. No other
family members reported diarrhea.
Three days after the interview, on
May 6, a formal complaint was pre-
sented by the mother at the Division
of Public Health of Lanús, in the
southern area of Buenos Aires, where
the family lives. The frozen leftover
ground beef from the same package
used to make the hamburgers was pro-
vided by the child’s family and
processed at the Laboratorio Central
de Salud Pública.
A 65-g portion of the ground beef
was incubated overnight at 42°C in
585 mL of modified E. coli medium
broth containing novobiocin (final
concentration, 20 µg/mL). The sam-
ple was positive using the E. coli
O157 Visual Immunoassay (Tecra
Internacional Pty. Ltd., French Forest
NSW, Australia) (8). Immuno-
magnetic separation was performed
with 1 mL of the culture, according to
the instructions of the manufacturer
(Dynal, Inc., Oslo, Norway). The con-
centrate sample was plated onto CT-
SMAC and O157:H7 ID medium
(bioMérieux, Marcy l’Etoile, France).
Up to 20 sorbitol-nonfermenting
colonies were selected, confirmed as
E. coli O157, and sent to NRL.
At NRL, both clinical and ground
beef O157 isolates were confirmed as
E. coli O157:H7, susceptible to all of
the antibiotics assayed, as previously
described (9). Genotypic characteriza-
tion showed that the isolates harbored
stx2, eae, and EHEC-hlyA genes. 
To establish their clonal related-
ness, the strains were assayed by sub-
typing methods (9). The identity of
the strains was confirmed by the
unique pulsed-field gel electrophore-
sis (PFGE) pattern with the restriction
enzymes XbaI and AvrII, and the same
phage type 4. In addition, both strains1186 Emerging Infectious Diseases • Vol. 9, No. 9, September 2003
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were characterized as stx2/stx2vh-a
by PCR-restriction fragment length
polymorphism. 
To our knowledge, this is the first
HUS case in our country in which the
source of infection was identified. No
investigation was conducted to trace
back the source of the ground beef.
This study illustrates the importance
of the surveillance of STEC infections
and the usefulness of molecular
subtyping techniques, such as PFGE
and phage typing, to determine the
relatedness of strains and assess
epidemiologic associations. 
The public should be made aware
that hamburgers, even when prepared
at home, can be a source of infection.
A primary strategy for preventing
infection with E. coli O157:H7 is
reducing risk behaviors through
consumer education (10).
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Q Fever in Thailand 
To the Editor: Coxiella burnetii, a
strict intracellular bacterium, is the
etiologic agent of Q fever, a world-
wide zoonosis. Humans are infected
by inhaling contaminated aerosols
from amniotic fluid or placenta or
handling contaminated wool (1). The
bacterium is highly infectious by the
aerosol route. Two forms of the dis-
ease are typical: acute and chronic.
Acute Q fever is the primary infection
and in specific hosts may become
chronic (1,2). The major clinical man-
ifestations of acute Q fever are pneu-
monia and hepatitis. Less common
clinical manifestations are aseptic
meningitis and/or encephalitis, pan-
creatitis, lymphadenopathy that mim-
ics lymphoma, erythrema nodosum,
bone marrow necrosis, hemolytic ane-
mia, and splenic rupture (2). The main
clinical manifestation of the chronic
form is culture-negative endocarditis,
but infection of vascular grafts or
aneurysms, hepatitis, osteomyelitis,
and prolonged fever have also been
described (1,2). Fluoroquinolones,
co-trimoxazole, and doxycycline are
active against C. burnetii in vitro, and
ceftriaxone has been shown to have a
bacteriostatic effect and could be
effective in the phagolysosome of C.
burnetii–infected cells (3). However,
the treatment of choice for Q fever is
doxycycline. 
The incidence of this disease is
largely unknown, especially in Asia.
Q fever has been reported from Japan
and China (1). Seroepidemiologic sur-
veys have shown that subclinical
infection is common worldwide.
Large outbreaks of Q fever have also
been reported in many countries in
Europe (4). A case series of acute Q
fever was diagnosed in a prospective
study in patients with acute febrile ill-
ness who were admitted to four hospi-
tals in northeastern Thailand:
Udornthani Hospital, Udornthani
Province; Maharat Nakhon Rtacha-
sima Hospital, Nakornrachasema Pro-